ArticleMedicina (Kaunas, Lithuania)2026
Immunosuppressive Tumor Microenvironment Signatures Predict Early Progression in NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Transcriptomic and Immune Deconvolution Analysis of GSE135222.
Hilmi Kodaz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.